Dacarbazine
- IVDacarbazine
Mechanism of Action
- Creates DNA adducts that cause base-base mismatches and DNA instability.
Clinical Use
Indications
- Certain solid organ and haematologic organ malignancies, as guided by cancer specialists and local guidelines.
- Adverse Effects
- Bone marrow suppression - leucopaenia, anaemia, thrombocytopaenia
- Nausea / vomiting / diarrhoea